查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1514901

狂犬病疫苗市場，按產品類型、應用、預防類型、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Rabies Vaccine Market, By Product Type, By Application, By Prophylaxis Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 367 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年狂犬病疫苗市場規模為13.4543億美元，2024年至2032年複合年成長率為4.5%。

狂犬病疫苗市場-市場動態

寵物數量的增加和獸醫護理的相應增加強調了寵物疫苗接種的必要性

飼養寵物的趨勢不斷成長，加上人們對獸醫護理意識的不斷增強，凸顯了寵物疫苗接種的重要性。隨著越來越多的家庭歡迎寵物進入家庭，確保這些動物免受可預防疾病的侵害成為當務之急。疫苗可以保護寵物免受各種嚴重且可能致命的疾病，例如狂犬病、犬瘟熱、細小病毒和貓白血病。據調查，印度有超過3,100萬隻寵物狗。屋主比租屋者更有可能擁有寵物：58% 的屋主養狗，36% 的屋主養貓，而租屋者的比例分別為 39% 和 29%。 11% 的印度人至少擁有四隻寵物。隨著寵物飼養量的不斷增加，重視疫苗接種對於保障寵物及其人類同伴的健康至關重要。定期接種疫苗是負責任的寵物照護的重要組成部分，可確保寵物活得更長、更健康，同時保護公眾健康。

狂犬病疫苗市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 4.5% 左右的複合年成長率成長

根據預防類型細分，預計暴露前預防將在 2023 年顯示最大的市場佔有率

從應用細分來看，2023年醫院是主導類型

根據應用細分，動物是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

狂犬病疫苗市場-細分分析：

全球狂犬病疫苗市場根據產品類型、應用、預防類型、最終用戶和地區進行細分。

根據預防類型，市場分為兩類：暴露前預防和暴露後預防。暴露前預防提供了長期保護，這減少了在可能接觸狂犬病的情況下及時進行暴露後護理的要求。當考慮到暴露後預防的費用時，從長遠來看，這種長期保護可能被證明是具有成本效益的。

根據最終用戶，市場分為三類：醫院、獸醫診所和其他。全球寵物擁有率的提高導致對獸醫服務的需求增加，包括狂犬病疫苗接種。獸醫診所為寵物（包括狗和貓）提供的預防性護理包括常規疫苗接種計劃。定期加強接種疫苗對於維持免疫力至關重要。加強接種的頻率取決於所使用的疫苗和當地法律，但通常範圍從每年一次到每三年一次。

狂犬病疫苗市場 - 地理洞察

由於產品引進率高、主要製造商的存在以及政府推廣狂犬病疫苗接種的活動，北美是狂犬病疫苗的重要市場。三個主要貢獻者是美國、加拿大和墨西哥，其中美國由於其先進的醫療保健系統和高度的意識而處於領先地位。由於廣泛使用疫苗作為疾病預防策略以及為醫療保健行業的研究和開發提供有利的環境，北美在市場佔有率方面處於領先地位。根據美國疾病預防控制中心估計，美國每年與狂犬病檢測和預防相關的醫療費用已超過3億美元。

狂犬病疫苗市場-競爭格局：

賽諾菲（法國）、默克公司、輝瑞公司（美國）、VBI Vaccines Inc.（美國）、CSC Pharmaceuticals International、Bio-Med Pvt.有限公司、巴伐利亞北歐（美國）、索爾維（美國）、Informa plc。 （美國）和其他主要參與者都參與了該市場。為了支持市場的整體成長，這些產業參與者正在實施多種方法，包括產能擴張、併購、合作夥伴關係、新產品開發和收購。此外，在分析期間，主要產業參與者在研發方面的投資不斷增加將支持市場擴張。例如，2024 年3 月，作為根除狂犬病持續承諾的一部分，新澤西州拉威市默克公司(Merck & Co., Inc.) 的子公司默克動物保健公司(Merck Animal Health) 向全球獸醫局( WVS) 捐贈了NOBIVAC(R) 狂犬病疫苗) 狂犬病任務計畫。未來五年，這些捐款將繼續支持這個非營利組織的年度狂犬病疫苗需求。

最近的發展：

2024 年 2 月，美國生物技術公司 Replicate Bioscience 公佈了積極的初步資料，其自我複製 RNA (srRNA) 狂犬病疫苗 RBI-4000 對狂犬病病毒實現了強烈的免疫反應。

2022 年 3 月，牛津大學和 Ifakara 健康研究所宣佈為坦尚尼亞人類志願者測試新型狂犬病疫苗的 Ib/II 期試驗的第一批參與者接種疫苗。

目錄

第1章：狂犬病疫苗市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的狂犬病疫苗市場片段
    • 狂犬病疫苗市場片段（依應用）
    • 按預防類型分類的狂犬病疫苗市場片段
    • 最終用戶的狂犬病疫苗市場片段
    • 按國家/地區分類的狂犬病疫苗市場摘要
    • 按地區分類的狂犬病疫苗市場片段
  • 競爭洞察

第 3 章：狂犬病疫苗主要市場趨勢

  • 狂犬病疫苗市場促進因素
    • 市場促進因素的影響分析
  • 狂犬病疫苗市場限制
    • 市場限制影響分析
  • 狂犬病疫苗市場機會
  • 狂犬病疫苗市場未來趨勢

第 4 章：狂犬病疫苗產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：狂犬病疫苗市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：狂犬病疫苗市場格局

  • 2023 年狂犬病疫苗市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：狂犬病疫苗市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • Vero 細胞狂犬病疫苗
    • 小倉鼠腎 (BHK)
    • 雞胚細胞狂犬病疫苗
    • 其他

第 8 章：狂犬病疫苗市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 人類
    • 動物

第 9 章：狂犬病疫苗市場 - 依預防類型

  • 概述
    • 按預防類型分類的細分市場佔有率分析
    • 暴露前預防
    • 暴露後預防

第 10 章：狂犬病疫苗市場 - 按最終用戶

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 醫院
    • 獸醫診所
    • 其他

第 11 章：狂犬病疫苗市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美狂犬病疫苗主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按預防類型）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲狂犬病疫苗主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按預防類型）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區狂犬病疫苗主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模與預測（依預防類型）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲狂犬病疫苗主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模與預測（按預防類型）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲狂犬病疫苗主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按預防類型）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 狂犬病疫苗產業

  • 競爭儀表板
  • 公司簡介
    • Serum Institute of India Pvt. Ltd
    • Novartis AG
    • Cadila Pharmaceuticals
    • Merck & Co., Inc.
    • Sanofi
    • ADS Diagnostic Ltd
    • GSK plc
    • Berna Biotech Pharma GmbH
    • AstraZeneca
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3021

REPORT HIGHLIGHT

Rabies Vaccine Market size was valued at USD 1,345.43 million in 2023, expanding at a CAGR of 4.5% from 2024 to 2032.

Growing pet ownership and the corresponding rise in veterinary care emphasize the need for pet vaccinations, thereby expanding the market. Ongoing research and development leading to improved vaccines with better efficacy, longer protection, and fewer side effects stimulate market demand. Increased awareness about rabies prevention and the importance of vaccination through educational campaigns positively impacts market growth. However, there are concerns over potential side effects and adverse reactions that can deter individuals from getting vaccinated.

Rabies Vaccine Market- Market Dynamics

Growing pet ownership and the corresponding rise in veterinary care emphasize the need for pet vaccinations

The growing trend in pet ownership, coupled with an increasing awareness of veterinary care, underscores the importance of pet vaccinations. As more households welcome pets into their families, ensuring these animals are protected against preventable diseases becomes a top priority. Vaccines protect pets from a variety of serious and potentially fatal diseases, such as rabies, distemper, parvovirus, and feline leukemia. According to the survey, there are over 31 million pet dogs in India. Homeowners are more likely to own pets than renters: 58% of homeowners have a dog and 36% have a cat versus 39% and 29% of renters respectively. 11% of people in India own at least four pets. As pet ownership continues to rise, the emphasis on vaccinations is essential for safeguarding the health of pets and their human companions. Regular vaccinations are a vital component of responsible pet care, ensuring that pets live longer, healthier lives while also protecting public health.

Rabies Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.5% over the forecast period (2024-2032)

Based on Prophylaxis Type segmentation, Pre-Exposure Prophylaxis was predicted to show maximum market share in the year 2023

Based on application segmentation, Hospitals were the leading type in 2023

Based on application segmentation, the animal was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Rabies Vaccine Market- Segmentation Analysis:

The Global Rabies Vaccine Market is segmented based on Product Type, Application, Prophylaxis Type, End User, and Region.

The market is divided into two categories based on prophylaxis type: Pre-Exposure Prophylaxis, and Post-Exposure Prophylaxis. Long-term protection is provided by pre-exposure prophylaxis, which lessens the requirement for prompt post-exposure care in the event of a possible rabies exposure. When post-exposure prophylaxis costs are taken into account, this long-term protection may prove to be cost-effective in the long run.

The market is divided into three categories based on end-users: Hospitals, Veterinary clinics, and Others. The increased global pet ownership rate has led to a larger need for veterinary services, including rabies vaccinations. The preventative care that veterinary clinics offer to pets, including dogs and cats, includes routine vaccination programs. Regular booster vaccinations are essential for maintaining immunity. The frequency of boosters depends on the vaccine used and local laws, but it generally ranges from annually to every three years.

Rabies Vaccine Market- Geographical Insights

Due to a high rate of product introductions, the existence of major manufacturers, and government campaigns to promote rabies vaccination, North America is a substantial market for rabies vaccines. Three major contributors are the United States, Canada, and Mexico with the United States leading because of its sophisticated healthcare system and high degree of awareness. North America leads the area in terms of market share due to the widespread use of vaccines as a disease prevention strategy and a conducive environment for research and development in the healthcare industry. According to estimates from the Centres for Disease Prevention and Prevention, the annual health costs in America related to the detection and prevention of rabies have surpassed USD 300 million.

Rabies Vaccine Market- Competitive Landscape:

Sanofi (France), Merck & Co. Inc., Pfizer (USA), VBI Vaccines Inc. (USA), CSC Pharmaceuticals International, Bio-Med Pvt. Ltd., Bavarian Nordic (USA), Solvay (USA), Informa plc. (USA), and other major players are among those involved in the market. To support the market's overall growth, these industry players are implementing several methods, including capacity expansion, mergers and acquisitions, partnerships, new product development, and acquisitions. Additionally, during the analysis period, growing investments made in research & development by the major industry players would support market expansion. For instance, In March 2024, As part of its ongoing commitment to eradicating rabies, Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., donated NOBIVAC(R) rabies vaccines to the Worldwide Veterinary Service (WVS) Mission Rabies program. Over the next five years, the donations will continue to support this non-profit organization's annual rabies vaccine requirements.

Recent Developments:

In February 2024, US-based biotech Replicate Bioscience announced positive preliminary data where its self-replicating RNA (srRNA) rabies vaccine, RBI-4000 achieved a strong immune response against the rabies virus.

In March 2022, The University of Oxford and the Ifakara Health Institute announced the vaccination of the first participants in a Phase Ib/II trial testing a novel rabies vaccine in human volunteers in Tanzania.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RABIES VACCINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Serum Institute of India Pvt. Ltd

Novartis AG

Cadila Pharmaceuticals

Merck & Co., Inc.

Sanofi

ADS Diagnostic Ltd

GSK plc

Berna Biotech Pharma GmbH

AstraZeneca

Others

GLOBAL RABIES VACCINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Vero Cell Rabies Vaccine
  • Baby Hamster Kidney (BHK)
  • Chick Embryo Cell Rabies Vaccine
  • Others

GLOBAL RABIES VACCINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Human
  • Animal

GLOBAL RABIES VACCINE MARKET, BY PROPHYLAXIS TYPE - MARKET ANALYSIS, 2019 - 2032

  • Pre-Exposure Prophylaxis
  • Post-Exposure Prophylaxis

GLOBAL RABIES VACCINE MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Veterinary clinics
  • Others

GLOBAL RABIES VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Rabies Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Rabies Vaccine Market Snippet by Product Type
    • 2.1.2. Rabies Vaccine Market Snippet by Application
    • 2.1.3. Rabies Vaccine Market Snippet by Prophylaxis Type
    • 2.1.4. Rabies Vaccine Market Snippet by End User
    • 2.1.5. Rabies Vaccine Market Snippet by Country
    • 2.1.6. Rabies Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Rabies Vaccine Key Market Trends

  • 3.1. Rabies Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Rabies Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Rabies Vaccine Market Opportunities
  • 3.4. Rabies Vaccine Market Future Trends

4. Rabies Vaccine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Rabies Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Rabies Vaccine Market Landscape

  • 6.1. Rabies Vaccine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Rabies Vaccine Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Vero Cell Rabies Vaccine
    • 7.1.3. Baby Hamster Kidney (BHK)
    • 7.1.4. Chick Embryo Cell Rabies Vaccine
    • 7.1.5. Others

8. Rabies Vaccine Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Human
    • 8.1.3. Animal

9. Rabies Vaccine Market - By Prophylaxis Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Prophylaxis Type, 2023 & 2032 (%)
    • 9.1.2. Pre-Exposure Prophylaxis
    • 9.1.3. Post-Exposure Prophylaxis

10. Rabies Vaccine Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Veterinary clinics
    • 10.1.4. Others

11. Rabies Vaccine Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Rabies Vaccine Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Rabies Vaccine Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Rabies Vaccine Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Rabies Vaccine Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Rabies Vaccine Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Rabies Vaccine Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Serum Institute of India Pvt. Ltd
    • 12.2.2. Novartis AG
    • 12.2.3. Cadila Pharmaceuticals
    • 12.2.4. Merck & Co., Inc.
    • 12.2.5. Sanofi
    • 12.2.6. ADS Diagnostic Ltd
    • 12.2.7. GSK plc
    • 12.2.8. Berna Biotech Pharma GmbH
    • 12.2.9. AstraZeneca
    • 12.2.10. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Rabies Vaccine Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Rabies Vaccine Market, by Product Type 2019-2032 (USD Million)
  • TABLE Rabies Vaccine Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Rabies Vaccine Market, by Application 2019-2032 (USD Million)
  • TABLE Rabies Vaccine Market: Prophylaxis Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Prophylaxis Type
  • TABLE Global Rabies Vaccine Market, by Prophylaxis Type 2019-2032 (USD Million)
  • TABLE Rabies Vaccine Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Rabies Vaccine Market, by End User 2019-2032 (USD Million)
  • TABLE Rabies Vaccine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Rabies Vaccine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Rabies Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Rabies Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Rabies Vaccine Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Rabies Vaccine Market, by Prophylaxis Type, 2019-2032 (USD Million)
  • TABLE North America Rabies Vaccine Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Rabies Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Rabies Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Rabies Vaccine Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Rabies Vaccine Market, by Prophylaxis Type, 2019-2032 (USD Million)
  • TABLE Europe Rabies Vaccine Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rabies Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rabies Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rabies Vaccine Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rabies Vaccine Market, by Prophylaxis Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rabies Vaccine Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Rabies Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Rabies Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Rabies Vaccine Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Rabies Vaccine Market, by Prophylaxis Type, 2019-2032 (USD Million)
  • TABLE Latin America Rabies Vaccine Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rabies Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rabies Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rabies Vaccine Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rabies Vaccine Market, by Prophylaxis Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rabies Vaccine Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Rabies Vaccine Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Prophylaxis Type segment market share analysis, 2023 & 2032
  • FIGURE Prophylaxis Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Rabies Vaccine Market share and leading players, 2023
  • FIGURE Europe Rabies Vaccine Market share and leading players, 2023
  • FIGURE Asia Pacific Rabies Vaccine Market share and leading players, 2023
  • FIGURE Latin America Rabies Vaccine Market share and leading players, 2023
  • FIGURE Middle East and Africa Rabies Vaccine Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Rabies Vaccine Market share analysis by country, 2023
  • FIGURE Germany Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Rabies Vaccine Market share analysis by country, 2023
  • FIGURE India Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Rabies Vaccine Market share analysis by country, 2023
  • FIGURE Brazil Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Rabies Vaccine Market share analysis by country, 2023
  • FIGURE Saudi Arabia Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)